|
| Status |
Public on Dec 31, 2017 |
| Title |
Duke/RG_Runx1Runx2_v1 (Agilent 4x180k) |
| Technology type |
in situ oligonucleotide |
| Distribution |
custom-commercial |
| Organism |
Homo sapiens |
| Manufacturer |
Agilent Technologies |
| Manufacture protocol |
In situ oligosynthesized array with proprietary synthetic sequences that target Runx1/Runx2 putative binding sites in genomic context.
|
| |
|
| |
|
| Submission date |
Apr 12, 2017 |
| Last update date |
Dec 31, 2017 |
| Contact name |
Raluca Gordan |
| E-mail(s) |
raluca.gordan@duke.edu
|
| Organization name |
Duke University
|
| Department |
Center for Genomic and Computational Biology
|
| Street address |
101 Science Dr, CIEMAS 2179
|
| City |
Durham |
| State/province |
NC |
| ZIP/Postal code |
27708 |
| Country |
USA |
| |
|
| Samples (4) |
GSM2575567, GSM2575568, GSM2575569, GSM2575570 |
| Series (2) |
| GSE97691 |
Divergence in DNA specificity among paralogous transcription factors contributes to their differential in vivo binding [RG_Runx1Runx2_v1] |
| GSE97794 |
Divergence in DNA specificity among paralogous transcription factors contributes to their differential in vivo binding |
|
